行情

MDCO

MDCO

麦迪逊医药
NASDAQ

实时行情|Nasdaq Last Sale

84.90
-0.06
-0.07%
已退市 19:47 01/03 EST
开盘
84.96
昨收
84.96
最高
84.98
最低
84.88
成交量
1,559.47万
成交额
--
52周最高
84.98
52周最低
18.83
市值
67.86亿
市盈率(TTM)
-27.1073
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测MDCO价格均价为86.43,最高价位95.00,最低价为85.00。

EPS

MDCO 新闻

更多
  • Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
  • Benzinga · 02/18 18:00
  • Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
  • Zacks · 02/07 14:36
  • Novartis to speed access to $10 billion heart drug via NHS deal
  • Reuters · 01/13 18:04
  • The Medicines Company Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022, 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 2024
  • Business Wire · 01/06 18:12

所属板块

制药
-0.81%
制药与医学研究
-1.01%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

MDCO 简况

The Medicines Company is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery of medicines to the hospital marketplace around the world. It markets Angiomax (bivalirudin), Ionsys (fentanyl iontophoretic transdermal system), Minocin (minocycline) for injection and Orbactiv (oritavancin). It also has a pipeline of products in development, including Carbavance, inclisiran and MDCO-700. Carbavance is used for the treatment of hospitalized patients with gram-negative bacterial infections. Inclisiran is used for the treatment of hypercholesterolemia. MDCO-700 includes sedative-hypnotic, which is used to induce and maintain sedation for procedural care and general anesthesia for surgical care. In addition to these products and products in development, it has a portfolio of generic drugs.
展开

微牛提供The Medicines Company(NASDAQ-MDCO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的MDCO股票新闻,以帮助您做出投资决策。